Operating
Stock-Based Comp
Gilead Sciences Stock-Based Comp decreased by 5.2% to $218.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.3%, from $209.00M to $218.00M. Over 4 years (FY 2021 to FY 2025), Stock-Based Comp shows an upward trend with a 8.9% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
An increase may signal a strategy to preserve cash or align employee interests with shareholders, but it also results in share dilution.
Detailed definition
Stock-based compensation is a non-cash expense where employees and executives are rewarded with equity or stock options...
Peer comparison
High-growth technology firms often have higher stock-based compensation as a percentage of revenue compared to mature industrial firms.
Metric ID:
stock_based_compensationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $166.00M | $171.00M | $159.00M | $130.00M | $165.00M | $168.00M | $174.00M | $165.00M | $198.00M | $202.00M | $201.00M | $187.00M | $210.00M | $216.00M | $222.00M | $209.00M | $225.00M | $230.00M | $230.00M | $218.00M |
| QoQ Change | — | +3.0% | -7.0% | -18.2% | +26.9% | +1.8% | +3.6% | -5.2% | +20.0% | +2.0% | -0.5% | -7.0% | +12.3% | +2.9% | +2.8% | -5.9% | +7.7% | +2.2% | +0.0% | -5.2% |
| YoY Change | — | — | — | — | -0.6% | -1.8% | +9.4% | +26.9% | +20.0% | +20.2% | +15.5% | +13.3% | +6.1% | +6.9% | +10.4% | +11.8% | +7.1% | +6.5% | +3.6% | +4.3% |
Range$130.00M – $230.00M
CAGR+5.9%
Avg YoY Growth+10.0%
Median YoY Growth+8.3%
Stock-Based Comp at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's stock-based comp?
- Gilead Sciences (GILD) reported stock-based comp of $218.00M in Q1 2026.
- How has Gilead Sciences's stock-based comp changed year-over-year?
- Gilead Sciences's stock-based comp increased by 4.3% year-over-year, from $209.00M to $218.00M.
- What is the long-term trend for Gilead Sciences's stock-based comp?
- Over 4 years (2021 to 2025), Gilead Sciences's stock-based comp has grown at a 8.9% compound annual growth rate (CAGR), from $635.00M to $894.00M.
- What does stock-based comp mean?
- The value of company shares given to employees as part of their pay.